World of DTC Marketing

JUNE 24, 2021

As we have seen over the past few years, Pharma companies are a business, a regulated business, but still a business. To portray patients, mindless people who blindly believe DTC TV ads and rush to their doctor to ask for a product are inaccurate. The latest TV upfront set some records because people ARE watching TV again.

Doctors 165

Doctors Doctor Production Drugs 165

World of DTC Marketing

MARCH 6, 2022

The excitement about these technologies partially stems from their potential to address health care system challenges that have slightly improved with traditional health care processes, payment models, regulations, guidelines, and innovations such as drugs and devices.

Production 244

Production Doctors Doctor Branding 244

pharmaphorum

JANUARY 8, 2021

According to the figures compiled in the third quarter of last year, pharma brands were projected to spend around $10 billion in 2020 on digital advertising aimed at all groups including doctors, a compound annual growth rate of more than 13% since 2014. This is an increase in 14.2% billion in 2021, an 18% increase.

Marketing 100

Marketing Doctors Doctor Pharma Companies 100

XTalks

JANUARY 17, 2024

Estimates based on publicly available information suggest more than 40 percent of all new therapies in development are cancer treatments. There are many aspects of oncology drug development that are driven by the unique nature of the treatments being developed and the needs of the patients, their caregivers and the doctors that treat them.

Clinical Trials 124

Clinical Trials Clinical Trials Trials Gene Therapy 124

pharmaphorum

JUNE 3, 2021

The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval. Instead, doctors have to look at a child’s developmental history and behaviour over time before making a diagnosis.

Doctors 114

Doctors Doctor Radiology Development 114

World of DTC Marketing

DECEMBER 2, 2021

The FDA wrote, “the researchers concluded that drug companies who create drug advertisements, as well as regulators who are responsible for reviewing promotional material, should pay special attention to ensuring that images accurately reflect drug efficacy.” ” Uh…no. appeared first on World of DTC Marketing.com.

Drugs 185

Drugs Doctors Doctor Research 185

Drug Discovery World

NOVEMBER 27, 2023

Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. Technological innovations supporting discovery and development stages have concentrated on both upstream and downstream aspects of the workflow. This article is sponsored by Revvity.

Production 59

Production Engineer Gene Editing Gene 59

Worldwide Clinical Trials

NOVEMBER 10, 2023

At this year’s annual Pain Therapeutics Summit , which took place in San Diego, CA, October 19 to 20th, I heard brilliant presentations on novel pain medication development, targeted discoveries, pain classifications, the NIH HEAL Initiative , trial designs, biomarkers, and others.

Clinical Trials 184

Clinical Trials Clinical Trials Trials Compliance 184

XTalks

APRIL 6, 2022

The personalized ctDNA blood test uses the RaDaR™ assay, a liquid biopsy platform developed by the company Inivata. Register for this webinar to get an overview of the role of long non-protein coding RNAs (lncRNAs) in gene regulations. Photo source: Inivata. Around 85 percent of cases are non-small cell lung cancer (NSCLC).

DNA 105

DNA In-Vitro Doctors Doctor 105

pharmaphorum

DECEMBER 1, 2022

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. Cloud platforms can open two-way communication channels for patients, doctors, and trial administrators to talk and share data, essentially in real-time. About the author.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Clinical Research 111

XTalks

MAY 11, 2023

Related: Abbott Baby Formula Plant Under Investigation by the DOJ Symptoms of Cronobacter Sakazakii Infection Infants are particularly vulnerable to Cronobacter sakazakii infections, as their immune systems are still developing and their digestive tracts are not fully formed.

Bacteria 98

Bacteria Doctors Doctor Contamination 98

pharmaphorum

SEPTEMBER 23, 2020

We’ve come so far in developing solutions for many big disease areas and healthcare. Asked how companies were encouraging this convergence – and the benefits it could bring — Ekdahl highlights recruitment, education, and regulation. Innovation versus regulation. Practical steps.

Life Science 140

Life Science Regulation Doctors Doctor 140

pharmaphorum

OCTOBER 1, 2021

Pharma has been talking about patient-centricity for years, but often that rhetoric hasn’t been accompanied by real change in product development, says Syneos Health’s Keri McDonough. Post-COVID evolution of pharma-doctor digital interactions. Pharma is embracing patient centricity in drug development.

Doctors 52

Doctors Doctor Marketing Branding 52

pharmaphorum

JANUARY 6, 2021

The regulator said it wanted more long-term safety and efficacy data from the REGENERATE study before making a final decision on the drug, which had been expected to be the first entrant into a likely multi-billion dollar market niche. billion annually if approved.

Gene Silencing 52

Gene Silencing Regulation Pharma Companies Doctors 52

pharmaphorum

JANUARY 24, 2022

“The cost of developing a new drug is extortionately high,” said Landray, adding that a very large proportion of those costs is in phase 3, and that means many promising therapies may never be taken forward by pharma companies.

Trials 97

Trials Drugs Clinical Trials Clinical Trials 97

pharmaphorum

NOVEMBER 3, 2020

The reason why competition regulators were concerned about Otezla was BMS’ deucravacitinib, which was in Bristol’s pipeline when the $74 billion merger was being finalised last year. Also known as BMS-986165, BMS was developing the drug as a potential best-in-class oral therapy with a different mechanism of action and cleaner safety profile.

Doctors 52

Doctors Doctor Trials Regulation 52

pharmaphorum

SEPTEMBER 24, 2020

An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. It’s reported that parents can often spot the early signs of developmental problems within 18 months.

Behavioural Health 134

Behavioural Health Doctors Doctor Development 134

The Pharma Data

DECEMBER 17, 2020

COVID-19 vaccine developers are faced with an ethical quandary — whether to let phase 3 trial participants become “unblinded” and to receive authorized vaccines as they become available, which could hinder the collection of meaningful trial data. Pfizer, which has received emergency approvals in the U.S.

Vaccination 52

Vaccination Vaccine Trials Development 52

pharmaphorum

NOVEMBER 1, 2021

Patient centricity isn’t a box ticking exercise – it’s a mindset that has to run the entire length of the drug development pathway. We need to engage with them if we are to develop new products and solutions that create better health for everyone,” she said. Patients are experts in their disease, not in clinical development.

Clinical Trials 89

Clinical Trials Clinical Trials Trials Production 89

Drug Discovery World

FEBRUARY 1, 2023

But more robust studies are needed across the board to help with the discovery and development of cannabis-based pharmaceuticals. There are more than 1300 clinical trials on cannabis underway and companies focused on the cultivation and manufacturing of cannabis are also educating doctors and patients about its potential pharmaceutical use.

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Trials 52

pharmaphorum

FEBRUARY 28, 2022

Many of the small challenges that face individual doctors and patients in seeking to find a solution for a rare disease also contribute to the difficulty of researching and developing an effective treatment. The highlighted issues are just a few of reasons that make developing treatments in the area of rare diseases a challenging one.

Gene Therapy 104

Gene Therapy Gene Development Medicine 104

pharmaphorum

OCTOBER 3, 2022

Pharma hasn’t fully moved into the experiential content space and is stuck on brand-centric content, which is not as engaging as experiential content that can make one question how a product impacts their life and how it helps doctors treat their patients better, Kapoor reasons. ” About the interviewee.

Branding 116

Branding Doctors Doctor Compliance 116

pharmaphorum

DECEMBER 21, 2020

But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against the COVID-19 scourge. billion in a series of private funding rounds, while fiercely guarding any details about the technology it was developing.

Vaccination 111

Vaccination Vaccine Doctors Doctor 111

The Pharma Data

JUNE 2, 2022

As part of the FDA’s ongoing efforts to build awareness around dietary supplements, Supplement Your Knowledge includes the following materials: For consumers: Public education videos and fact sheets with important information about dietary supplements, including how they are regulated and potential benefits and risks. Source link: [link].

Regulation 52

Regulation Production Cosmetics Nurses 52

pharmaphorum

FEBRUARY 3, 2021

France’s SurgAR has joined with imaging data firm Medexprim to form a three-year partnership with a major hospital in France, to develop augmented reality (AR) software dedicated to laporoscopic surgery. The University Hospital Centre of Clermont-Ferrand has been ranked in the top 20 French hospitals for nine years and has 7,000 staff.

Radiology 69

Radiology Compliance Doctors Doctor 69

pharmaphorum

NOVEMBER 27, 2018

Patient level data offers the promise of insights which can craft new and better pathways, enable development of innovative therapies and treatments, and of course identify and prevent diseases much earlier in their lifecycle. One area of particular interest is cancer. So, what is the solution?

Doctors 52

Doctors Doctor Regulation Development 52

pharmaphorum

JANUARY 29, 2021

This has, of course, garnered immense excitement – Doctors Emmanuelle Charpentier and Jennifer Doudna were named winners of the Nobel Prize for chemistry in recognition of their discovery of CRISPR/Cas9 gene editing technology. Since Macrae joined the company just four years ago, Sangamo has more than tripled its staff and raised $1.6

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

APRIL 20, 2021

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator. . Relapsing and remitting forms of MS account for around 85% of all patients at diagnosis, although some go on to develop more progressive forms.

Sales 111

Sales Medicine Drugs Marketing 111

FDA Law Blog

MARCH 13, 2023

Valentine — Incorporating patient and caregiver experiences into every phase of drug development has become increasingly prioritized during both development and review ( see, e.g. , previous coverage here ). There have been challenges in gene therapy development. By Larry J. Bauer, Senior Regulatory Drug Expert & James E.

Gene Therapy 98

Gene Therapy Gene Trials Clinical Trials 98

Camargo

JULY 30, 2021

I’ve been in the pediatric arena since 1976, and in those days, I was going to develop my career in pediatric oncology, specifically acute lymphocytic leukemia (ALL). In 1981, I got my doctorate degree in Clinical Pharmacology, but more importantly, my research was heavily involved in neonatal medicine, developing drugs there.

Clinical Research 226

Clinical Research Research Gene Therapy Gene 226

pharmaphorum

AUGUST 8, 2022

The US regulator has approved Nubeqa (darolutamide) in combination with docetaxel chemotherapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC), adding to its earlier indication in non-metastatic castration-resistant prostate cancer (nmCRPC). billion) blockbuster.

Sales 59

Sales Hormones FDA Approval Marketing 59

pharmaphorum

JANUARY 7, 2021

Used with widely available PET scan technology, ImaginAb’s technology allows doctors to track the T-cell immune response to cancer in real time and it has already picked up a multi-party deal involving Pfizer, AstraZeneca and Takeda.

Doctors 53

Doctors Doctor Immune Response Pharma Companies 53

pharmaphorum

SEPTEMBER 17, 2020

While tests of the vaccine co-developed with Oxford University have resumed in the UK, experts from the US National Institutes of Health have launched an investigation into the incident, which is still being kept under wraps by the UK pharma for patient confidentiality reasons.

Vaccination 105

Vaccination Vaccine Trials Doctors 105

pharmaphorum

MAY 14, 2021

China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial.

Drug Trials 52

Drug Trials Trials Drugs Dermatology 52

pharmaphorum

OCTOBER 5, 2021

Digital data collection, utilisation of real-word data and patient-centric thinking will all contribute to the rapid development of a new healthcare landscape, says Debiopharm Innovation Fund’s Tanja Dowe. The time of individuals relying entirely on face-to-face interaction with their doctors is long past.

Doctors 132

Doctors Doctor Marketing Development 132

Find Me Cure

APRIL 16, 2020

Yet, there is only so much that can be done to simplify the path to accessing treatments in development. You found our platform on social media or through a friend or a patient organisation, or maybe even your doctor recommended it. There are also some variations in the regulations from one continent or country to another.

Clinical Trials 68

Clinical Trials Clinical Trials Trials Doctors 68

FDA Law Blog

FEBRUARY 21, 2022

Unger’s Office oversaw the approval and regulation of scores of new drugs for cardiovascular, renal, neurological, and psychiatric disorders. Drug development attorney (and guru) Frank Sasinowski commented: “We are honored to have Dr. Unger join us in aiding patients, researchers and sponsors bring new therapies to those in need of them.

Drugs 40

Drugs Cardiology FDA Approval Doctors 40